✦ LIBER ✦
Interleukin 2 receptor targeted fusion toxin (DAB486-IL-2) treatment blocks diabetogenic autoimmunity in non-obese diabetic mice
✍ Scribed by Alvaro Pacheco-Silva; Marcus G. Bastos; Robert A. Muggia; Oleh Pankewycz; Jean Nichols; John R. Murphy; Terry B. Strom; Vicki E. Rubin-Kelley
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 630 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.